Suppr超能文献

胸椎手术后患者自控硬膜外镇痛中加入静脉注射氯胺酮是否有益?一项随机双盲研究。

Is there any benefit to adding intravenous ketamine to patient-controlled epidural analgesia after thoracic surgery? A randomized double-blind study.

机构信息

Intensive Care and Anesthesiology Unit 2, Timone/Sainte-Marguerite Hospital, Assistance Publique-Hôpitaux de Marseille, Marseille, France.

出版信息

Eur J Cardiothorac Surg. 2012 Oct;42(4):e58-65. doi: 10.1093/ejcts/ezs398. Epub 2012 Jul 12.

Abstract

OBJECTIVES

Thoracic surgery is associated with severe acute postoperative pain, leading to pulmonary complications and hyperalgesia-induced chronic pain. Thoracic patient-controlled epidural analgesia is also considered as the gold-standard postoperative analgesia. As previously described in major digestive surgery, combination with low-dose intravenous (i.v.) ketamine could potentiate epidural analgesia and facilitate pulmonary function recovery following thoracotomy.

METHODS

In a randomized, double-blind trial, 60 patients scheduled to undergo thoracotomy were included. All patients received a thoracic epidural catheter placed before surgery, and standardized general anaesthesia. They were allocated to two groups to receive either an i.v. bolus of ketamine at induction, followed by a continuous infusion during surgery and the first 48 h postoperatively, or an i.v. placebo (a saline solution under the same infusion modalities). Cumulative epidural ropivacaine consumption, postoperative pain scores (patient self-rated numeric pain intensity scale), analgesic rescue consumption, residual pain, haemodynamics and respiratory recovery function were recorded from 12 h to 3 months. Data were expressed as mean ± standard deviation or median ± interquartile range (25-75%). The comparisons between ketamine and placebo groups were performed using χ(2) or Fisher's exact tests for frequencies, and Mann-Whitney tests for quantitative variables.

RESULTS

Epidural ropivacaine consumption was similar between groups during the first 48 postoperative hours. Postoperative pain scores and spirometric parameters were not significantly different between groups. But the incidence of postoperative nausea was significantly increased in patients owning to the ketamine group. Finally, the incidence of residual pain was similar between groups at 1 and 3 months following thoracotomy.

CONCLUSIONS

Adding i.v. ketamine did not potentiate epidural analgesia neither to reduce acute and chronic postoperative pain nor to improve pulmonary dysfunction following thoracic surgery. Pain scores were low in both groups, mainly because of an optimized analgesia provided by the patient-controlled epidural mode, and might explain this lack of benefit in adding i.v. ketamine.

摘要

目的

胸部手术会引起严重的急性术后疼痛,导致肺部并发症和痛觉过敏引起的慢性疼痛。胸部患者自控硬膜外镇痛也被认为是术后镇痛的金标准。如前所述,在大型消化手术中,联合小剂量静脉(i.v.)氯胺酮可以增强硬膜外镇痛作用,并促进开胸手术后肺功能的恢复。

方法

在一项随机、双盲试验中,纳入了 60 名计划接受开胸手术的患者。所有患者在手术前均放置了胸部硬膜外导管,并接受了标准化的全身麻醉。他们被分为两组,一组在诱导时静脉注射氯胺酮,然后在手术期间和术后前 48 小时内持续输注,另一组静脉注射安慰剂(相同输注方式下的生理盐水溶液)。从 12 小时到 3 个月,记录累积硬膜外罗哌卡因消耗、术后疼痛评分(患者自评数字疼痛强度量表)、镇痛补救消耗、残留疼痛、血流动力学和呼吸恢复功能。数据表示为均值±标准差或中位数±四分位间距(25-75%)。使用 χ(2)或 Fisher 确切检验比较频率,使用 Mann-Whitney 检验比较定量变量,比较氯胺酮组和安慰剂组之间的差异。

结果

在术后前 48 小时,两组硬膜外罗哌卡因消耗相似。两组患者术后疼痛评分和肺功能参数无显著差异。但氯胺酮组患者术后恶心发生率明显升高。最后,两组患者术后 1 个月和 3 个月时的残留疼痛发生率相似。

结论

静脉注射氯胺酮不能增强硬膜外镇痛作用,既不能减轻急性和慢性术后疼痛,也不能改善开胸手术后的肺功能障碍。两组患者的疼痛评分均较低,主要是由于患者自控硬膜外模式提供了优化的镇痛,这可能解释了在添加静脉注射氯胺酮时缺乏益处。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验